The implementation nightmare: TMS
Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hanselmann A, et al
The two medications have different dose schedules, different side-effect profiles, and different insurance coverage pathways
Additionally, certain early signals including a possible association between GLP-1 use and elevated kidney cancer risk, as well as questions regarding long-term thyroid safety underscore the importance of individualised clinical assessment and ongoing medical supervision
ACT 2: What Insurance Coverage Will Actually Look Like The second layer of the access problem is insurance, and the precedent is genuinely discouraging
When you eat a surplus, your body decides where the extra energy goes based on a stack of hormonal signals